Related Experiment Video
Updated: Jan 31, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Lessons from basic pancreatic beta cell research in type-2 diabetes and vascular complications
Lena Eliasson1, Jonathan Lou S Esguerra1, Anna Wendt1
1Islet Cell Exocytosis, Department of Clinical Sciences Malmö, Lund University Diabetes Centre, Lund University, Clinical Research Centre, SUS 91-11, Box 50332, 202 13 Malmö, Sweden.
Lifestyle changes fuel obesity, type 2 diabetes, and cardiovascular disease. This review explores pancreatic beta cell dysfunction, lipid influences, statin effects on glucose, and microRNAs (miRNAs) in diabetes pathogenesis and prediction.
Area of Science:
- Endocrinology and Metabolism
- Molecular Biology
- Cardiovascular Science
Background:
- Global obesity epidemic linked to lifestyle changes, increasing type 2 diabetes and cardiovascular disease.
- Pancreatic beta cells are crucial for insulin secretion; impaired function is an early sign of diabetes.
- Cardiovascular disease patients often receive statins, prompting investigation into their metabolic effects.
Purpose of the Study:
- To explain cellular mechanisms behind reduced first-phase insulin response in diabetes.
- To review the impact of lipids and statins on glucose homeostasis and insulin secretion.
- To highlight the role of microRNAs (miRNAs) in beta cell function and diabetes development.
Main Methods:
- Literature review based on a foreign investigator award lecture.
- Discussion of cellular mechanisms of insulin secretion.
- Summary of recent data on statin effects and miRNA involvement in diabetes.
Main Results:
- Lipids can influence first-phase insulin response in pancreatic beta cells.
- Statins may affect glucose homeostasis and insulin secretion.
- MicroRNAs are implicated in regulating insulin secretion and are differentially expressed in type 2 diabetes.
Conclusions:
- Understanding lipid and statin effects on beta cells is crucial for managing diabetes and cardiovascular disease.
- MicroRNAs show potential as biomarkers for predicting diabetes and associated cardiovascular complications.
- Targeting miRNAs could offer novel therapeutic strategies for type 2 diabetes.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Energy Basics
Hemodialysis II: Procedure and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

